122 related articles for article (PubMed ID: 10563153)
1. [Reduction in the rates of restenosis after coronary angioplasty with simvastatin and probucol].
Merchán Herrera A; López Mínguez JR; Alonso Ruiz F; Escola JM; Címbora Ortega A; Poblador Curto MA; Redondo Méndez A; Romero Santisteban R; Geniz Gallardo I; González Fernández R; Millán Núñez V
Rev Esp Cardiol; 1999 Oct; 52(10):778-84. PubMed ID: 10563153
[TBL] [Abstract][Full Text] [Related]
2. Probucol therapy in the prevention of restenosis after successful percutaneous transluminal coronary angioplasty.
Setsuda M; Inden M; Hiraoka N; Okamoto S; Tanaka H; Okinaka T; Nishimura Y; Okano H; Kouji T; Konishi T
Clin Ther; 1993; 15(2):374-82. PubMed ID: 8519045
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of an antioxidant in preventing restenosis after percutaneous transluminal coronary angioplasty: the Probucol Angioplasty Restenosis Trial.
Yokoi H; Daida H; Kuwabara Y; Nishikawa H; Takatsu F; Tomihara H; Nakata Y; Kutsumi Y; Ohshima S; Nishiyama S; Seki A; Kato K; Nishimura S; Kanoh T; Yamaguchi H
J Am Coll Cardiol; 1997 Oct; 30(4):855-62. PubMed ID: 9316509
[TBL] [Abstract][Full Text] [Related]
4. [Preventive effect of pravastatin on restenosis following coronary angioplasty: prospective randomized trial].
Iwasaki K; Kusachi S; Hina K; Yamasaki S; Nishiyama O; Takaishi A; Kita T; Taniguchi G
J Cardiol; 1995 Jan; 25(1):15-21. PubMed ID: 7877098
[TBL] [Abstract][Full Text] [Related]
5. [New strategies in the treatment of restenosis].
von Hodenberg E; Tost B; Scheffold T
Z Kardiol; 2000; 89 Suppl 7():19-22. PubMed ID: 11098555
[TBL] [Abstract][Full Text] [Related]
6. Helicobacter pylori (H. pylori) infection in coronary artery disease: influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. The detection of H. pylori specific DNA in human coronary atherosclerotic plaque.
Kowalski M
J Physiol Pharmacol; 2001 Aug; 52(1 Suppl 1):3-31. PubMed ID: 11795863
[TBL] [Abstract][Full Text] [Related]
7. [Anti-atherogenic drugs].
Kanaki T; Saito Y
Nihon Rinsho; 1998 Oct; 56(10):2635-9. PubMed ID: 9796331
[TBL] [Abstract][Full Text] [Related]
8. Preventive effects of probucol on restenosis after percutaneous transluminal coronary angioplasty.
Watanabe K; Sekiya M; Ikeda S; Miyagawa M; Hashida K
Am Heart J; 1996 Jul; 132(1 Pt 1):23-9. PubMed ID: 8701872
[TBL] [Abstract][Full Text] [Related]
9. Randomized comparison of J&J Crown stent versus NIR stent after routine coronary angioplasty.
Miketic S; Carlsson J; Tebbe U
Am Heart J; 2001 Nov; 142(5):E8. PubMed ID: 11685183
[TBL] [Abstract][Full Text] [Related]
10. Prevention of restenosis by bezafibrate after successful coronary angioplasty.
Ishiwata S; Nakanishi S; Nishiyama S; Seki A
Coron Artery Dis; 1995 Nov; 6(11):883-9. PubMed ID: 8696533
[TBL] [Abstract][Full Text] [Related]
11. Intensive cholesterol lowering with statin improves the outcomes of percutaneous coronary intervention in patients with acute coronary syndrome.
Jia XW; Fu XH; Zhang J; Gu XS; Fan WZ; Wu WL; Hao GZ; Li SQ; Jiang YF
Chin Med J (Engl); 2009 Mar; 122(6):659-64. PubMed ID: 19323930
[TBL] [Abstract][Full Text] [Related]
12. [Role of new devices for angioplasty in the unprotected left main coronary artery].
Kosuga K; Tamai H; Kyo E; Hata T; Okada M; Nakamura T; Fujita S; Komori H; Tsuji T; Takeda S; Motohara S; Uehata H
J Cardiol; 2001 Nov; 38(5):245-53. PubMed ID: 11729724
[TBL] [Abstract][Full Text] [Related]
13. [Ticlopidine may prevent subtotal or total occlusion of dilated lesions after percutaneous coronary angioplasty].
Kitazume H; Ageishi Y; Iwama T; Kubo I; Suzuki A
J Cardiol; 1993; 23(2):149-55. PubMed ID: 8176626
[TBL] [Abstract][Full Text] [Related]
14. Probucol and multivitamins in the prevention of restenosis after coronary angioplasty. Multivitamins and Probucol Study Group.
Tardif JC; Cöté G; Lespérance J; Bourassa M; Lambert J; Doucet S; Bilodeau L; Nattel S; de Guise P
N Engl J Med; 1997 Aug; 337(6):365-72. PubMed ID: 9241125
[TBL] [Abstract][Full Text] [Related]
15. Stent placement compared with balloon angioplasty for obstructed coronary artery disease in Thai elderly patients: initial result and 6 months follow-up.
Panchavinnin P; Tresukosol D; Phankingthongkum R; Sriyuthasak O; Sahasakul Y; Thongsawas R
J Med Assoc Thai; 2004 Mar; 87(3):225-32. PubMed ID: 15117037
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of probucol in preventing restenosis after percutaneous transluminal coronary angioplasty.
Lee YJ; Daida H; Yokoi H; Miyano H; Takaya J; Sakurai H; Mokuno H; Yamaguchi H
Jpn Heart J; 1996 May; 37(3):327-32. PubMed ID: 8774625
[TBL] [Abstract][Full Text] [Related]
17. Effects of simvastatin only or in combination with continuous combined hormone replacement therapy on serum lipid levels in hypercholesterolaemic post-menopausal women.
Fak AS; Erenus M; Tezcan H; Caymaz O; Atagündüz P; Oktay S; Oktay A
Eur Heart J; 2000 Feb; 21(3):190-7. PubMed ID: 10639300
[TBL] [Abstract][Full Text] [Related]
18. [Results of coronary heart disease treatment with coronary angioplasty in patient over 65].
Chizyński K
Przegl Lek; 2003; 60(7):456-60. PubMed ID: 14750418
[TBL] [Abstract][Full Text] [Related]
19. [Is Palmaz-Schatz stenting effective for second restenosis?].
Kishi K; Hiasa Y; Suzuki N; Miyamoto H; Takahashi T; Hosokawa S; Tanimoto M; Otani R
J Cardiol; 1999 Nov; 34(5):243-8. PubMed ID: 10579132
[TBL] [Abstract][Full Text] [Related]
20. Effect of probucol on repeat revascularization rate after percutaneous transluminal coronary angioplasty (from the Probucol Angioplasty Restenosis Trial [PART]).
Daida H; Kuwabara Y; Yokoi H; Nishikawa H; Takatsu F; Nakata Y; Kutsumi Y; Oshima S; Nishiyama S; Ishiwata S; Kato K; Nishimura S; Miyauchi K; Kanoh T; Yamaguchi H
Am J Cardiol; 2000 Sep; 86(5):550-2, A9. PubMed ID: 11009277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
